We make diagnostics that matter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe, it’s free!
  • Search
  • Menu Menu
Clinical Laboratory int.

Archive for category: Featured Articles

Featured Articles

ECCMID 2024 will take place 27-30 April 2024 in Barcelona, Spain.

Gilead Sciences announces positive results from Veklury and obeldesivir trials

, 26 May 2023/in Featured Articles /by panglobal

Gilead Sciences announces positive results from Veklury and obeldesivir trials Gilead Sciences, announced positive results from several COVID-19 clinical and real-world evidence studies presented at ECCMID. A Phase 3 clinical study demonstrated that Veklury (remdesivir) was generally well tolerated in people with moderate to severe renal impairment. Additional data includes a retrospective real-world study which […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/ECCMID4.jpg 1180 1512 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 10:09:032023-05-26 10:09:03Gilead Sciences announces positive results from Veklury and obeldesivir trials
Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue

Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue

, 26 May 2023/in Featured Articles /by panglobal

Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue Axcella Therapeutics – a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions – gave two oral presentations of results from the Phase 2a clinical trial of AXA1125 in the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/ECCMID2.jpg 1390 1412 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 10:04:382023-05-26 10:04:38Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue
ECCMID ESCMID

Shionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections

, 26 May 2023/in Featured Articles /by panglobal

Shionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections At ECCMID 2023, Osaka, Japan-based Shionogi announced key data for cefiderocol, an innovative siderophore cephalosporin, including new real-world evidence demonstrating its efficacy against some of the most difficult-to-treat Gram-negative bacterial infections.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/ECCMID_logo.png 644 1136 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 09:57:132023-05-26 09:57:13Shionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections
ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics

ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics

, 26 May 2023/in Featured Articles /by panglobal

ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics Also at ECCMID, ELITech Group unveiled the upcoming launch of a new high throughput sample-to-result instrument for molecular diagnostics.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/ECCMID1.jpg 1920 1440 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 09:48:192023-05-26 09:51:31ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics
Influential ECCMID 2023 sees numerous scientific presentations

Influential ECCMID 2023 sees numerous scientific presentations

, 26 May 2023/in Featured Articles /by panglobal

Influential ECCMID 2023 sees numerous scientific presentations The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) took place in Copenhagen, Denmark, 15-18 April 2023. With around 14,000 professional attendees ECCMID is the largest international meeting of clinical microbiologists and infectious diseases specialists. The event included a comprehensive scientific programme, an industry programme and […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/ECCMID3.jpg 1478 1780 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 09:44:462023-05-26 09:55:22Influential ECCMID 2023 sees numerous scientific presentations
Figure 1. Calibrator and control positioning in robot racks

Faster throughput – together | New streamlined solution for immunosuppressant analysis by LC-MS/MS

, 26 May 2023/in Featured Articles /by panglobal

Faster throughput – together | New streamlined solution for immunosuppressant analysis by LC-MS/MS by Mikaël Levi To face increasing demands on their time and resources, chemical laboratories need easier-to-handle solutions with faster turnaround times, lower costs per sample and full compliance with ever-stricter regulatory standards. Recent work by Alsachim using Shimadzu equipment and software has […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Figure_1_CMYK.jpg 1440 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 09:18:342023-05-26 09:32:38Faster throughput – together | New streamlined solution for immunosuppressant analysis by LC-MS/MS
Biomarkers and preanalytics in Alzheimer’s disease

Biomarkers and preanalytics in Alzheimer’s disease

, 26 May 2023/in Featured Articles /by panglobal

by Dr Jacqueline Gosink Biomarkers and preanalytics in Alzheimer’s disease Analysis of biomarkers such as amyloid-beta peptides and tau proteins in cerebrospinal fluid (CSF) is nowadays a core criterion in Alzheimer’s disease diagnostics. Test methods such as ELISA and chemiluminescence immunoassay enable robust and reproducible measurement of the analytes in patient CSF samples. Recommendations for […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/shutterstock_2111097938.jpg 832 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 08:41:042023-05-26 08:54:48Biomarkers and preanalytics in Alzheimer’s disease
Figure 1. Respondents gained a variety of INTEGRA pipetting solutions during the pandemic to handle high sample numbers

Responding to a global health crisis: the evolution of the lab

, 26 May 2023/in Featured Articles /by panglobal

by Dr Éva Mészáros Responding to a global health crisis: the evolution of the lab The COVID-19 pandemic forced life sciences laboratories all over the world to suddenly begin high volume PCR testing, to help gain the upper hand over this deadly disease. Many facilities had to adopt new pipetting platforms at short notice to […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Graph-00.jpg 451 900 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 07:40:382023-05-26 08:16:29Responding to a global health crisis: the evolution of the lab
Four saliva samples containing SARS-CoV-2 RNA were mixed with target-specific capture oligonucleotides attached to magnetic beads. The solutions were heated to 95°C for 1 minute, then placed in a rack with a magnet. After 3 minutes the supernatants were replaced with a 1-step RT-qPCR master mix and subjected to a rapid cycling protocol (1 second at 95°C/1 second at 65°C). The same concentration of four pure RNA samples were amplified at the same time and acted as positive controls. the RNA extracted from saliva recorded the same quantification cycles (blue) as the untreated control RNA (red).

Remodelling qPCR as a tool for molecular diagnostics

, 26 May 2023/in Featured Articles /by panglobal

by Professor Stephen Bustin   Remodelling qPCR as a tool for molecular diagnostics PCR is an incredibly powerful tool in the field of molecular diagnostics, and its current role is embedded in the clinical laboratory where it is indispensable for non-time-critical routine testing. However, point-of-care testing via lateral flow devices, as seen in the recent […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Fig-3.jpeg 768 1024 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-26 07:22:492023-05-26 08:20:09Remodelling qPCR as a tool for molecular diagnostics
Safety of blood and plasma products from pathogen transmission

Safety of blood and plasma products from pathogen transmission

, 25 May 2023/in Featured Articles /by panglobal

‘The Expert Report to the Infected Blood Inquiry: Statistics’ (http://bitly.ws/EAng) found that around 3650 people with bleeding disorders in the UK were infected with HIV or hepatitis viruses through the use of contaminated blood products. In addition, many people (8120) were found to be chronically infected with hepatitis C 10 years or more after receiving […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Employees-working-in-the-Plasma-Purification-Area.jpg 1281 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-05-25 15:11:352023-05-25 15:11:35Safety of blood and plasma products from pathogen transmission
Page 1 of 136123›»
We make diagnostics that matter

Latest issue of Clinical laboratory

February 2023 / March 2023

IH Cover magazine FEB MRT
26 May 2023

Scientists identify new biomarker that may predict treatment response to chemoimmunotherapy

26 May 2023

Researchers discover a way to improve nonviral gene editing as well as a new type of DNA repair

26 May 2023

Ziath’s new RFID tagging technology streamlines cryogenic sample management

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Hastelweg 250
5652 CN Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only